Publications

  1. Daidone S, Unlu H, Yehia A, Zhang N, Abulseoud OA. Severe alcohol withdrawal during pregnancy or early postpartum: maternal and fetal outcomes. Arch Womens Ment Health. 2024 Nov 11 [Epub ahead of print]
    View PubMed
  2. Yehia A, Abulseoud OA. Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration. Mol Neurodegener. 2024 Apr 19; 19 (1):36
    View PubMed
  3. Unlu H, Yehia A, El-Gayar S, Havanur A, Brown SJ, Deceus FG, Umar S, Croakin PE, Schneekloth TD, Abulseoud OA. Clinical characteristics, and treatment outcome of alcohol withdrawal syndrome in adolescents and young adults. JAACP-Open (In Press). 2024.
  4. Donlon J, Kumari P, Varghese SP, Bai M, Florentin OD, Frost ED, Banks J, Vadlapatla N, Kam O, Shad MU, Rahman S, Abulseoud OA, Stone TW, Koola MM. Integrative Pharmacology in the Treatment of Substance Use Disorders. J Dual Diagn. 2024 Apr-Jun; 20 (2):132-177 Epub 2023 Dec 20
    View PubMed
  5. Abulseoud OA, Caparelli EC, Krell-Roesch J, Geda YE, Ross TJ, Yang Y. Sex-difference in the association between social drinking, structural brain aging and cognitive function in older individuals free of cognitive impairment. Front Psychiatry. 2024; 15:1235171 Epub 2024 Apr 08
    View PubMed
  6. El-Sayed W, Hussein AM, Elmenshawi I, Helal G, Abbas M, Badawy A, Kiwan NA, El Tohamy M, Awadalla G, Abulseoud OA. Association of glutamine synthetase polymorphisms rs2296521, rs10911021 and rs12136955 with plasma ammonia concentration in valproic acid-treated Egyptian epilepsy patients. Neurol Neurochir Pol. 2024; 58 (5):519-530 Epub 2024 Aug 21
    View PubMed
  7. Unlu H, Yehia A, Manji K, Manji N, Trevino-Alvarez AM, Cabeza De Baca T, Frye MA, Thomas LF, Abulseoud OA. Bidirectional negative relationship between thyrotropin and kidney function during alcohol intoxication in males. Front Nephrol. 2024; 4:1322791 Epub 2024 Aug 08
    View PubMed
  8. Abulseoud OA, Chan B, Rivera-Chiauzzi EY, Egol CJ, Nettey VN, Van Ligten MJ, Griffin TN, Aly M, Sinha S, Schneekloth TD. Psychiatric disorders during pregnancy in asymptomatic and mildly symptomatic SARS-CoV-2 positive women: Prevalence and effect on outcome. Psychiatry Res. 2023 Aug; 326:115313 Epub 2023 June 16
    View PubMed
  9. Rydberg A, Dodoo CA, Schneekloth TD, Abulseoud OA. No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users. J Cannabis Res. 2023 Jun 19; 5 (1):23 Epub 2023 June 19
    View PubMed
  10. ElShebiney S, Elgohary R, El-Shamarka M, Mowaad N, Abulseoud OA. Natural Polyphenols-Resveratrol, Quercetin, Magnolol, and beta-Catechin-Block Certain Aspects of Heroin Addiction and Modulate Striatal IL-6 and TNF-alpha. Toxics. 2023 Apr 17; 11 (4)
    View PubMed
  11. Yehia A, Sousa RAL, Abulseoud OA. Sex difference in the association between blood alcohol concentration and serum ferritin. Front Psychiatry. 2023; 14:1230406 Epub 2023 July 21
    View PubMed
  12. Sousa RAL, Yehia A, Abulseoud OA. Attenuation of ferroptosis as a potential therapeutic target for neuropsychiatric manifestations of post-COVID syndrome. Front Neurosci. 2023; 17:1237153 Epub 2023 July 24
    View PubMed
  13. Unlu H, Macaron MM, Ayraler Taner H, Kaba D, Akin Sari B, Schneekloth TD, Leggio L, Abulseoud OA. Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies. Front Psychiatry. 2023; 14:1266424 Epub 2023 Sept 22
    View PubMed
  14. Yuen J, Goyal A, Rusheen AE, Kouzani AZ, Berk M, Kim JH, Tye SJ, Abulseoud OA, Oesterle TS, Blaha CD, Bennet KE, Lee KH, Oh Y, Shin H. Oxycodone-induced dopaminergic and respiratory effects are modulated by deep brain stimulation. Front Pharmacol. 2023; 14:1199655 Epub 2023 June 20
    View PubMed
  15. Caparelli EC, Schleyer B, Zhai T, Gu H, Abulseoud OA, Yang Y. High-Frequency Transcranial Magnetic Stimulation Combined With Functional Magnetic Resonance Imaging Reveals Distinct Activation Patterns Associated With Different Dorsolateral Prefrontal Cortex Stimulation Sites. Neuromodulation. 2022 Jun; 25 (4):633-643 Epub 2022 Apr 10
    View PubMed
  16. Angebrandt A, Abulseoud OA, Kisner M, Diazgranados N, Momenan R, Yang Y, Stein EA, Ross TJ. Dose-dependent relationship between social drinking and brain aging. Neurobiol Aging. 2022 Mar; 111:71-81 Epub 2021 Dec 02
    View PubMed
  17. Abulseoud OA, Alasmari F, Hussein AM, Sari Y. Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation. Front Neurosci. 2022; 16:841036 Epub 2022 July 05
    View PubMed
  18. Caparelli EC, Abulseoud OA, Gu H, Zhai T, Schleyer B, Yang Y. Low frequency repetitive transcranial magnetic stimulation to the right dorsolateral prefrontal cortex engages thalamus, striatum, and the default mode network. Front Neurosci. 2022; 16:997259 Epub 2022 Sept 30
    View PubMed
  19. Macaron MM, Segun-Omosehin OA, Matar RH, Beran A, Nakanishi H, Than CA, Abulseoud OA. A systematic review and meta analysis on burnout in physicians during the COVID-19 pandemic: A hidden healthcare crisis. Front Psychiatry. 2022; 13:1071397 Epub 2023 Jan 12
    View PubMed
  20. Abulseoud OA, Yehia A, Egol CJ, Nettey VN, Aly M, Qu Y, Skolnik AB, Grill MF, Sen A, Schneekloth TD. Attenuated initial serum ferritin concentration in critically ill coronavirus disease 2019 geriatric patients with comorbid psychiatric conditions. Front Psychiatry. 2022; 13:1035986 Epub 2022 Nov 09
    View PubMed
  21. Montemitro C, Angebrandt A, Wang TY, Pettorruso M, Abulseoud OA. Mechanistic insights into the efficacy of memantine in treating certain drug addictions. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20; 111:110409 Epub 2021 July 27
    View PubMed
  22. McLaughlin NCR, Dougherty DD, Eskandar E, Ward H, Foote KD, Malone DA, Machado A, Wong W, Sedrak M, Goodman W, Kopell BH, Issa F, Shields DC, Abulseoud OA, Lee K, Frye MA, Widge AS, Deckersbach T, Okun MS, Bowers D, Bauer RM, Mason D, Kubu CS, Bernstein I, Lapidus K, Rosenthal DL, Jenkins RL, Read C, Malloy PF, Salloway S, Strong DR, Jones RN, Rasmussen SA, Greenberg BD. Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design. Contemp Clin Trials Commun. 2021 Jun; 22:100785 Epub 2021 June 05
    View PubMed
  23. Badawy AA, Elghaba R, Soliman M, Hussein AM, AlSadrah SA, Awadalla A, Abulseoud OA. Chronic Valproic Acid Administration Increases Plasma, Liver, and Brain Ammonia Concentration and Suppresses Glutamine Synthetase Activity. Brain Sci. 2020 Oct 21; 10 (10)
    View PubMed
  24. Huestis MA, Sempio C, Newmeyer MN, Andersson M, Barnes AJ, Abulseoud OA, Blount BC, Schroeder J, Smith ML. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users. J Anal Toxicol. 2020 Oct 12; 44 (7):651-660
    View PubMed
  25. Abulseoud OA, Ross TJ, Nam HW, Caparelli EC, Tennekoon M, Schleyer B, Castillo J, Fedota J, Gu H, Yang Y, Stein E. Short-term nicotine deprivation alters dorsal anterior cingulate glutamate concentration and concomitant cingulate-cortical functional connectivity. Neuropsychopharmacology. 2020 Oct; 45 (11):1920-1930 Epub 2020 June 19
    View PubMed
  26. Ashley DL, De Jesus VR, Abulseoud OA, Huestis MA, Milan DF, Blount BC. Urinary Acrylonitrile Metabolite Concentrations Before and after Smoked, Vaporized, and Oral Cannabis in Frequent and Occasional Cannabis Users. Int J Environ Res Public Health. 2020 Sep 4; 17 (18) Epub 2020 Sept 04
    View PubMed
  27. Abulseoud OA, Senormanci G, Senormanci O, Guclu O, Schleyer B, Camsari U. Sex difference in the progression of manic symptoms during acute hospitalization: A prospective pilot study. Brain Behav. 2020 Mar; 10 (3):e01568 Epub 2020 Feb 13
    View PubMed
  28. Farokhnia M, McDiarmid GR, Newmeyer MN, Munjal V, Abulseoud OA, Huestis MA, Leggio L. Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Transl Psychiatry. 2020 Feb 19; 10 (1):71
    View PubMed
  29. Hussein AM, Eldosoky M, El-Shafey M, El-Mesery M, Abbas KM, Ali AN, Helal GM, Abulseoud OA. Effects of GLP-1 Receptor Activation on a Pentylenetetrazole-Kindling Rat Model. Brain Sci. 2019 May 14; 9 (5)
    View PubMed
  30. Hussein AM, Eldosoky M, El-Shafey M, El-Mesery M, Ali AN, Abbas KM, Abulseoud OA. Effects of metformin on apoptosis and a-synuclein in a rat model of pentylenetetrazole-induced epilepsy. Can J Physiol Pharmacol. 2019 Jan; 97(1):37-46.
  31. Hussein AM, Adel M, El-Mesery M, Abbas KM, Ali AN, Abulseoud OA. l-Carnitine Modulates Epileptic Seizures in Pentylenetetrazole-Kindled Rats via Suppression of Apoptosis and Autophagy and Upregulation of Hsp70. Brain Sci. 2018 Mar 14; 8 (3)
    View PubMed
  32. Gawad NA, Mohamed K, Choi DS, Abulseoud OA. No differences in manic-like behaviors between voluntary ethanol and water drinking in Lateral Hypothalamic Kindled (LHK) alcohol preferring rats. Psychiatry Res. 2018 Mar; 261:186-189. Epub 2018 Jan 02.
    View PubMed
  33. Steele VR, Maxwell AM, Ross TJ, Moussawi K, Abulseoud OA, Stein EA, Salmeron BJ. Report of transient events in a cocaine-dependent volunteer who received iTBS. Brain Stimul. 2018.
  34. Abulseoud OA, Zuccoli ML, Zhang L, Barnes A, Huestis MA, Lin DT. The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a translational study. Eur Neuropsychopharmacol. 2017 Jul; 27 (7):679-690 Epub 2017 Apr 26
    View PubMed
  35. Swortwood MJ, Newmeyer MN, Andersson M, Abulseoud OA, Scheidweiler KB, Huestis MA. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration. Drug Test Anal. 2017 Jun; 9 (6):905-915 Epub 2016 Oct 13
    View PubMed
  36. Gibson WS, Cho S, Abulseoud OA, Gorny KR, Felmlee JP, Welker KM, Klassen BT, Min HK, Lee KH. The Impact of Mirth-Inducing Ventral Striatal Deep Brain Stimulation on Functional and Effective Connectivity. Cereb Cortex. 2017 Mar 01; 27(3):2183-2194.
    View PubMed
  37. Abulseoud OA, Ho MC, Choi DS, Stanojevic A, Cupic Z, Kolar-Anic L, Vukojevic V. Corticosterone oscillations during mania induction in the lateral hypothalamic kindled rat-Experimental observations and mathematical modeling. PLoS One. 2017; 12 (5):e0177551 Epub 2017 May 18
    View PubMed
  38. Newmeyer MN, Swortwood MJ, Abulseoud OA, Huestis MA. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration. Drug Alcohol Depend. 2017; 175:67-76.
  39. Newmeyer MN, Swortwood MJ, Andersson M, Abulseoud OA, Scheidweiler KB, Huestis MA. Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Delta(9)-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie Administration. Clin Chem. 2017; 63(3):647-62.
  40. Newmeyer MN, Swortwood MJ, Taylor ME, Abulseoud OA, Woodward TH, Huesti MA. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration. J Appl Toxicol. 2017; 37(8):922-32.
  41. Weiss H, Lesage E, Salmeron BJ, Stein EA, Abulseoud OA. Brief rTMS delivered by H- Coil to a healthy volunteer induced delayed, transient hypomanic symptoms: A case report. Brain Stimul. 2017; 10(5):992-3.
  42. Hussein AM, Abbas KM, Abulseoud OA, El-Hussainy EMA. Effects of ferulic acid on oxidative stress, heat shock protein 70, connexin 43, and monoamines in the hippocampus of pentylenetetrazole- kindled rats. Can J Physiol Pharmacol. 2017; 95(6):732-42.
  43. Karpyak VM, Biernacka JM, Geske JR, Abulseoud OA, Brunner MD, Chauhan M, Hall-Flavin DK, Lewis KA, Loukianova LL, Melnyk GJ, Onsrud DA, Proctor BD, Schneekloth TD, Skime MK, Wittkopp JE, Frye MA, Mrazek DA. Gender-specific effects of comorbid depression and anxiety on the propensity to drink in negative emotional states. Addiction. 2016 Aug; 111 (8):1366-75 Epub 2016 May 05
    View PubMed
  44. Vadnie CA, Ayers-Ringler J, Oliveros A, Abulseoud OA, Choi S, Hitschfeld MJ, Choi DS. Antipsychotic-like effects of a neurotensin receptor type 1 agonist. Behav Brain Res. 2016 May 15; 305:8-17 Epub 2016 Feb 22
    View PubMed
  45. Abulseoud OA, Kasasbeh A, Min HK, Fields JA, Tye SJ, Goerss S, Knight EJ, Sampson SM, Klassen BT, Matsumoto JY, Stoppel C, Lee KH, Frye MA. Stimulation-Induced Transient Nonmotor Psychiatric Symptoms following Subthalamic Deep Brain Stimulation in Patients with Parkinson's Disease: Association with Clinical Outcomes and Neuroanatomical Correlates. Stereotact Funct Neurosurg. 2016; 94 (2):93-101 Epub 2016 Apr 20
    View PubMed
  46. Newmeyer MN, Swortwood MJ, Barnes AJ, Abulseoud OA, Scheidweiler KB, Huestis MA. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake. Clin Chem. 2016; 62(12):1579-92.
  47. Hussein AM, Ghalwash M, Magdy K, Abulseoud OA. Beta Lactams Antibiotic Ceftriaxone Modulates Seizures, Oxidative Stress and Connexin 43 Expression in Hippocampus of Pentylenetetrazole Kindled Rats. J Epilepsy Res. 2016; 6(1):8-15.
  48. Croarkin PE, Thomas MA, Port JD, Baruth JM, Choi DS, Abulseoud OA, Frye MA. N-acetylaspartate normalization in bipolar depression after lamotrigine treatment. Bipolar Disord. 2015 Jun; 17 (4):450-7 Epub 2014 Dec 12
    View PubMed
  49. Hitschfeld MJ, Schneekloth TD, Ebbert JO, Hall-Flavin DK, Karpyak VM, Abulseoud OA, Patten CA, Geske JR, Frye MA. Female smokers have the highest alcohol craving in a residential alcoholism treatment cohort. Drug Alcohol Depend. 2015 May 1; 150:179-82 Epub 2015 Feb 25
    View PubMed
  50. Abulseoud OA, Gawad NA, Mohamed K, Vadnie C, Camsari UM, Karpyak V, Frye MA, Choi DS. Sex differences in mania phenotype and ethanol consumption in the lateral hypothalamic kindled rat model. Transl Psychiatry. 2015 Mar 24; 5 (3):e534
    View PubMed
  51. Cuellar-Barboza AB, Frye MA, Grothe K, Prieto ML, Schneekloth TD, Loukianova LL, Hall-Flavin DK, Clark MM, Karpyak VM, Miller JD, Abulseoud OA. Change in consumption patterns for treatment-seeking patients with alcohol use disorder post-bariatric surgery. J Psychosom Res. 2015 Mar; 78 (3):199-204 Epub 2014 Sept 07
    View PubMed
  52. Abulseoud OA, Camsari UM, Ruby CL, Mohamed K, Abdel Gawad NM, Kasasbeh A, Yuksel MY, Choi DS. Lateral hypothalamic kindling induces manic-like behavior in rats: a novel animal model. Int J Bipolar Disord. 2014 Dec; 2 (1):7 Epub 2014 June 14
    View PubMed
  53. Karpyak VM, Biernacka JM, Geske JR, Jenkins GD, Cunningham JM, Ruegg J, Kononenko O, Leontovich AA, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Skime MK, Frank J, Nothen MM, Rietschel M, Kiefer F, Mann KF, Weinshilboum RM, Frye MA, Choi DS. Genetic markers associated with abstinence length in alcohol-dependent subjects treated with acamprosate. Transl Psychiatry. 2014 Oct 7; 4:e462 Epub 2014 Oct 07
    View PubMed
  54. Ruby CL, Vadnie CA, Hinton DJ, Abulseoud OA, Walker DL, O'Connor KM, Noterman MF, Choi DS. Adenosinergic regulation of striatal clock gene expression and ethanol intake during constant light. Neuropsychopharmacology. 2014 Sep; 39 (10):2432-40 Epub 2014 Apr 23
    View PubMed
  55. Chopra A, Abulseoud OA, Sampson S, Lee KH, Klassen BT, Fields JA, Matsumoto JY, Adams AC, Stoppel CJ, Geske JR, Frye MA. Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up study. Psychosomatics. 2014 Sep-Oct; 55 (5):478-84 Epub 2013 Dec 21
    View PubMed
  56. Abulseoud OA, Camsari UM, Ruby CL, Kasasbeh A, Choi S, Choi DS. Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2. Neuropsychopharmacology. 2014 Jun; 39 (7):1674-84 Epub 2014 Jan 23
    View PubMed
  57. Karpyak VM, Winham SJ, Biernacka JM, Cunningham JM, Lewis KA, Geske JR, Colby CL, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Frye MA, Heit JA, Mrazek DA. Association of GATA4 sequence variation with alcohol dependence. Addict Biol. 2014 Mar; 19 (2):312-5 Epub 2012 Aug 02
    View PubMed
  58. Sailasuta N, Harris KC, Tran TT, Abulseoud O, Ross BD. Impact of fasting on human brain acid-base homeostasis using natural abundance (13) C and (31) P MRS. J Magn Reson Imaging. 2014 Feb; 39(2):398-401. Epub 2013 Jun 03.
    View PubMed
  59. Hosain MD, Kouzani AZ, Tye SJ, Abulseoud OA, Amiet A, Galehdar A, Kaynak A, Berk M. Development of a Compact Rectenna for Wireless Powering of a Head-Mountable Deep Brain Stimulation Device. IEEE J Transl Eng Health Med. 2014; 2:1500113.
    View PubMed
  60. Kim JP, Min HK, Knight EJ, Duffy PS, Abulseoud OA, Marsh MP, Kelsey K, Blaha CD, Bennet KE, Frye MA, Lee KH. Centromedian-parafascicular deep brain stimulation induces differential functional inhibition of the motor, associative, and limbic circuits in large animals. Biol Psychiatry. 2013 Dec 15; 74 (12):917-926 Epub 2013 Aug 30
    View PubMed
  61. Kasasbeh A, Abulseoud OA, Matsumoto JY, Stead SM, Goerss SJ, Klassen BT, Huston J 3rd, Min HK, Lee KH, Frye MA. Lack of differential motor outcome with subthalamic nucleus region stimulation in Parkinson's disease. J Clin Neurosci. 2013 Nov; 20(11):1520-6. Epub 2013 Jul 29.
    View PubMed
  62. Abulseoud OA, Karpyak VM, Schneekloth T, Hall-Flavin DK, Loukianova LL, Geske JR, Biernacka JM, Mrazek DA, Frye MA. A retrospective study of gender differences in depressive symptoms and risk of relapse in patients with alcohol dependence. Am J Addict. 2013 Sep-Oct; 22 (5):437-42 Epub 2013 May 30
    View PubMed
  63. Karpyak VM, Winham SJ, Preuss UW, Zill P, Cunningham JM, Walker DL, Lewis KA, Geske JR, Colby CL, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Frye MA, Bazov I, Heit JA, Bakalkin G, Mrazek DA, Biernacka JM. Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states. Int J Neuropsychopharmacol. 2013 Jun; 16 (5):975-85 Epub 2012 Oct 29
    View PubMed
  64. Abulseoud OA, Ahmed AT, Nassi S, Vigen C. Thyroid Stimulating Hormone in Acute Psychiatric Patients with Positive Urine Toxicology Drug Screen: A Retrospective Study Journal of Alcoholism & Drug Dependence.. 2013.
  65. Abulseoud OA, Gitlin M, Altshuler L, Frye MA. Baseline thyroid indices and the subsequent response to citalopram treatment, a pilot study. Brain Behav. 2013 Mar; 3 (2):89-94 Epub 2013 Jan 18
    View PubMed
  66. Kouzani AZ, Abulseoud OA, Tye SJ, Hosain MD, Berk M. A Low Power Micro Deep Brain Stimulation Device for Murine Preclinical Research. IEEE J Transl Eng Health Med. 2013; 2:1500109 Epub 2013 June 04
    View PubMed
  67. Knight EJ, Min HK, Hwang SC, Marsh MP, Paek S, Kim I, Felmlee JP, Abulseoud OA, Bennet KE, Frye MA, Lee KH. Nucleus accumbens deep brain stimulation results in insula and prefrontal activation: a large animal FMRI study. PLoS One. 2013; 8 (2):e56640 Epub 2013 Feb 18
    View PubMed
  68. Hosain MK, Kouzani AZ, Tye SJ, Abulseoud OA, Berk M. Design and analysis of an antenna for wireless energy harvesting in a head-mountable DBS device. Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 2013; 3078-81.
  69. Abulseoud OA, Costales J, Peterson M, Miller JD, Lagomasino IT. The Prevalence of Adjunctive Antipsychotic Treatment for Non-Psychotic Predominantly Latino Depressed Adults; a Retrospective Study. Revista de Neuro- Psiquiatría. 2013; 76(4):224-30.
  70. Lingwood MD, Siaw TA, Sailasuta N, Abulseoud OA, Chan HR, Ross BD, Bhattacharya P, Han S. Hyperpolarized water as an MR imaging contrast agent: feasibility of in vivo imaging in a rat model. Radiology. 2012 Nov; 265(2):418-25. Epub 2012 Sep 20.
    View PubMed
  71. Mallory GW, Abulseoud O, Hwang SC, Gorman DA, Stead SM, Klassen BT, Sandroni P, Watson JC, Lee KH. The nucleus accumbens as a potential target for central poststroke pain. Mayo Clin Proc. 2012 Oct; 87 (10):1025-31 Epub 2012 Sept 12
    View PubMed
  72. Anderson RJ, Frye MA, Abulseoud OA, Lee KH, McGillivray JA, Berk M, Tye SJ. Deep brain stimulation for treatment-resistant depression: efficacy, safety and mechanisms of action. Neurosci Biobehav Rev. 2012 Sep; 36(8):1920-33. Epub 2012 Jun 18.
    View PubMed
  73. Abulseoud OA, Miller JD, Wu J, Choi DS, Holschneider DP. Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm. Brain Res. 2012 May 25; 1456:14-21 Epub 2012 Mar 27
    View PubMed
  74. Abulseoud O, Karpyak V, Schneekloth T, Hall-Flavin D, Loukianova L, Geske J, Biernacka, Mrazek D, Frye M. Negatively Valenced Emotional Stimuli are Associated with Heavy Drinking among Women with Alcohol-Dependence. American Journal of Addiction. 2012 (in press).
  75. Karpyak VM, Winham SJ, Biernacka JM, Preuss UW, Zill P, Cunningham JM, Walker DL, Lewis KA, Geske JR, Colby CL, Abulseoud OA, Hall-Flavin DK, Loukianova LL, Schneekloth TD, Frye MA, Heit JA, Bakalkin G, Mrazek DA. Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states. Addiction Biology.. 2012 (in press);
  76. Pato C, Abulseoud O, Pato M. The role of research in academic psychiatric departments: a case study. Acad Psychiatry. 2011 Mar-Apr; 35(2):139-42.
    View PubMed
  77. Altshuler LL, Abulseoud OA, Foland-Ross L, Bartzokis G, Chang S, Mintz J, Hellemann G, Vinters HV. Amygdala astrocyte reduction in subjects with major depressive disorder but not bipolar disorder. Bipolar Disord. 2010 Aug; 12(5):541-9.
    View PubMed
  78. Gitlin MJ, Abulseoud O, Frye MA. Improving the design of maintenance studies for bipolar disorder. Curr Med Res Opin. 2010 Aug; 26(8):1835-42.
    View PubMed
  79. Sailasuta N, Abulseoud O, Harris KC, Ross BD. Glial dysfunction in abstinent methamphetamine abusers. J Cereb Blood Flow Metab. 2010 May; 30(5):950-60. Epub 2009 Dec 30.
    View PubMed
  80. Sailasuta N, Abulseoud O, Hernandez M, Haghani P, Ross BD. Metabolic Abnormalities in Abstinent Methamphetamine Dependent Subjects. Subst Abuse. 2010 Apr 7; 2010(4):9-20.
    View PubMed
  81. Gropman AL, Sailasuta N, Harris KC, Abulseoud O, Ross BD. Ornithine transcarbamylase deficiency with persistent abnormality in cerebral glutamate metabolism in adults. Radiology. 2009 Sep; 252(3):833-41. Epub 2009 Jun 30.
    View PubMed
  82. Abulseoud OA, Hellmann G, Calabrese JR, Verduin ML, Chirichigno JW, McKowen J, Gitlin MJ, Altshuler LL, Frye MA. Sex and bipolar subtype association with self-reported hazardous alcohol consumption in bipolar depression. Journal of Dual Diagnosis. 2008; 4(3):291-302.
  83. Abulseoud O, Sane N, Cozzolino A, Kiriakos L, Mehra V, Gitlin M, Masseling S, Whybrow P, Altshuler LL, Mintz J, Frye MA. Free T4 index and clinical outcome in patients with depression. J Affect Disord. 2007 Jun; 100(1-3):271-7. Epub 2006 Nov 22.
    View PubMed
  84. Abulseoud O, Fayek M, Kingsbury SJ, Simpson GM. Patients' preference for conventional antipsychotic medications. Psychiatr Serv. 2002 May; 53(5):537-8, 547.
    View PubMed